Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea

The Korean Study Group for Candidemia

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Multicenter data on in vitro susceptibility of Candida bloodstream isolates to echinocandin antifungal agents is still lacking in South Korea. We performed a prospective multicenter study to determine the species distribution of Candida bloodstream isolates and their susceptibility to five antifungal agents, including caspofungin and micafungin. A total of 639 isolates were collected from 20 tertiary hospitals between September 2006 and August 2007. Antifungal susceptibilities were determined through the use of the CLSI broth microdilution method M27-A3. The overall species distribution was as follows; Candida albicans (38%), Candida parapsilosis (26%), Candia tropicalis (20%), Candida glabrata (11%), and miscellaneous Candida species (5%). Although C. parapsilosis and miscellaneous Candida species were less susceptible to both echinocandins, all 639 isolates were susceptible to both caspofungin and micafungin (MIC, ≤ 2 μg/ml). Nearly all isolates (99.7%) had a MIC ≤ 1 μg/ml to amphotericin B. Resistance to fluconazole and voriconazole was found in 0.8% and 0.3%, respectively, among all Candida isolates, with C. glabrata and C. krusei isolates displaying the greatest level of resistance. This is the largest multicenter candidemia study conducted in South Korea and shows that non-C. albicans Candida species, including C. parapsilosis, constitutes over 60% of all Candida species isolates recovered from the bloodstream. In addition, the rates of resistance to all five antifungals, including two echinocandins, are still low among bloodstream isolates in South Korea.

Original languageEnglish
Pages (from-to)669-674
Number of pages6
JournalMedical mycology
Volume48
Issue number4
DOIs
Publication statusPublished - 2010 Jan 1

Fingerprint

Republic of Korea
Candida
Echinocandins
caspofungin
Candida glabrata
Antifungal Agents
Candida albicans
Multicenter Studies
Candidemia
Fluconazole
Amphotericin B
Tertiary Care Centers
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Infectious Diseases

Cite this

@article{429dd4782f364aa192442b7d9791261d,
title = "Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea",
abstract = "Multicenter data on in vitro susceptibility of Candida bloodstream isolates to echinocandin antifungal agents is still lacking in South Korea. We performed a prospective multicenter study to determine the species distribution of Candida bloodstream isolates and their susceptibility to five antifungal agents, including caspofungin and micafungin. A total of 639 isolates were collected from 20 tertiary hospitals between September 2006 and August 2007. Antifungal susceptibilities were determined through the use of the CLSI broth microdilution method M27-A3. The overall species distribution was as follows; Candida albicans (38{\%}), Candida parapsilosis (26{\%}), Candia tropicalis (20{\%}), Candida glabrata (11{\%}), and miscellaneous Candida species (5{\%}). Although C. parapsilosis and miscellaneous Candida species were less susceptible to both echinocandins, all 639 isolates were susceptible to both caspofungin and micafungin (MIC, ≤ 2 μg/ml). Nearly all isolates (99.7{\%}) had a MIC ≤ 1 μg/ml to amphotericin B. Resistance to fluconazole and voriconazole was found in 0.8{\%} and 0.3{\%}, respectively, among all Candida isolates, with C. glabrata and C. krusei isolates displaying the greatest level of resistance. This is the largest multicenter candidemia study conducted in South Korea and shows that non-C. albicans Candida species, including C. parapsilosis, constitutes over 60{\%} of all Candida species isolates recovered from the bloodstream. In addition, the rates of resistance to all five antifungals, including two echinocandins, are still low among bloodstream isolates in South Korea.",
author = "{The Korean Study Group for Candidemia} and Jung, {Sook In} and Shin, {Jong Hee} and Song, {Jae Hoon} and Peck, {Kyong Ran} and Kyungwon Lee and Kim, {Mi Na} and Chang, {Hyun Ha} and Moon, {Chi Sook}",
year = "2010",
month = "1",
day = "1",
doi = "10.3109/13693780903410386",
language = "English",
volume = "48",
pages = "669--674",
journal = "Medical Mycology",
issn = "1369-3786",
publisher = "Informa Healthcare",
number = "4",

}

Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea. / The Korean Study Group for Candidemia.

In: Medical mycology, Vol. 48, No. 4, 01.01.2010, p. 669-674.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea

AU - The Korean Study Group for Candidemia

AU - Jung, Sook In

AU - Shin, Jong Hee

AU - Song, Jae Hoon

AU - Peck, Kyong Ran

AU - Lee, Kyungwon

AU - Kim, Mi Na

AU - Chang, Hyun Ha

AU - Moon, Chi Sook

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Multicenter data on in vitro susceptibility of Candida bloodstream isolates to echinocandin antifungal agents is still lacking in South Korea. We performed a prospective multicenter study to determine the species distribution of Candida bloodstream isolates and their susceptibility to five antifungal agents, including caspofungin and micafungin. A total of 639 isolates were collected from 20 tertiary hospitals between September 2006 and August 2007. Antifungal susceptibilities were determined through the use of the CLSI broth microdilution method M27-A3. The overall species distribution was as follows; Candida albicans (38%), Candida parapsilosis (26%), Candia tropicalis (20%), Candida glabrata (11%), and miscellaneous Candida species (5%). Although C. parapsilosis and miscellaneous Candida species were less susceptible to both echinocandins, all 639 isolates were susceptible to both caspofungin and micafungin (MIC, ≤ 2 μg/ml). Nearly all isolates (99.7%) had a MIC ≤ 1 μg/ml to amphotericin B. Resistance to fluconazole and voriconazole was found in 0.8% and 0.3%, respectively, among all Candida isolates, with C. glabrata and C. krusei isolates displaying the greatest level of resistance. This is the largest multicenter candidemia study conducted in South Korea and shows that non-C. albicans Candida species, including C. parapsilosis, constitutes over 60% of all Candida species isolates recovered from the bloodstream. In addition, the rates of resistance to all five antifungals, including two echinocandins, are still low among bloodstream isolates in South Korea.

AB - Multicenter data on in vitro susceptibility of Candida bloodstream isolates to echinocandin antifungal agents is still lacking in South Korea. We performed a prospective multicenter study to determine the species distribution of Candida bloodstream isolates and their susceptibility to five antifungal agents, including caspofungin and micafungin. A total of 639 isolates were collected from 20 tertiary hospitals between September 2006 and August 2007. Antifungal susceptibilities were determined through the use of the CLSI broth microdilution method M27-A3. The overall species distribution was as follows; Candida albicans (38%), Candida parapsilosis (26%), Candia tropicalis (20%), Candida glabrata (11%), and miscellaneous Candida species (5%). Although C. parapsilosis and miscellaneous Candida species were less susceptible to both echinocandins, all 639 isolates were susceptible to both caspofungin and micafungin (MIC, ≤ 2 μg/ml). Nearly all isolates (99.7%) had a MIC ≤ 1 μg/ml to amphotericin B. Resistance to fluconazole and voriconazole was found in 0.8% and 0.3%, respectively, among all Candida isolates, with C. glabrata and C. krusei isolates displaying the greatest level of resistance. This is the largest multicenter candidemia study conducted in South Korea and shows that non-C. albicans Candida species, including C. parapsilosis, constitutes over 60% of all Candida species isolates recovered from the bloodstream. In addition, the rates of resistance to all five antifungals, including two echinocandins, are still low among bloodstream isolates in South Korea.

UR - http://www.scopus.com/inward/record.url?scp=77952495875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952495875&partnerID=8YFLogxK

U2 - 10.3109/13693780903410386

DO - 10.3109/13693780903410386

M3 - Article

C2 - 20392145

AN - SCOPUS:77952495875

VL - 48

SP - 669

EP - 674

JO - Medical Mycology

JF - Medical Mycology

SN - 1369-3786

IS - 4

ER -